van Kuijk Jan-Peter, Dunkelgrun Martin, Schreiner Frodo, Flu Willem-Jan, Galal Wael, van Domburg Ron T, Hoeks Sanne E, van Gestel Yvette R B M, Bax Jeroen J, Poldermans Don
Department of Anesthesiology, Erasmus Medical Center, Rotterdam, The Netherlands.
Am Heart J. 2009 May;157(5):919-25. doi: 10.1016/j.ahj.2009.02.011.
Diabetes mellitus (DM) is an important risk factor in vascular surgery patients, influencing late outcome. Screening for diabetes is recommended by fasting glucose measurement. Oral glucose tolerance testing (OGTT) could enhance the detection of patients with impaired glucose tolerance (IGT) and DM.
To assess the additional value of OGTT on top of fasting glucose levels in vascular surgery patients to predict long-term cardiovascular outcome.
A total of 404 patients without signs or histories of IGT (plasma glucose 7.8-11.1 mmol/L) or DM (glucose >/=11.1 mmol/L) were prospectively included and subjected to OGTT. Cardiac risk factors were noted. Primary outcome was the occurrence of late cardiovascular events (composite of cardiovascular death, angina pectoris, myocardial infarction, percutaneous coronary intervention/coronary artery bypass grafting, or cerebral vascular accident/transient ischemic attack), and secondary outcome included all-cause and cardiovascular mortality rates, in survivors of vascular surgery. Median follow-up was 3.0 (interquartile range 2.4-3.8) years.
Impaired glucose tolerance (n = 104) and DM (n = 43) were detected by fasting glucose levels in 26 (25%) and 12 (28%) patients, and by OGTT in 78 (75%) and 31 (72%) patients, respectively. During follow-up, 131 patients experienced a cardiovascular event. With multivariable analysis, patients with IGT showed a significant increased risk for cardiovascular events (hazard ratio 2.77, 95% CI 1.83-4.20) and mortality (hazard ratio 2.06, 95% CI 1.03-4.12). Patients with DM showed a nonsignificant increased risk for cardiovascular events.
Vascular surgery patients with IGT or DM detected by preoperative OGTT have an increased risk of developing cardiovascular events and mortality during long-term follow-up. It is recommended that nondiabetic vascular surgery patients should be tested for glucose regulation disorders before surgery.
糖尿病(DM)是血管外科手术患者的一个重要危险因素,会影响远期预后。建议通过空腹血糖检测来筛查糖尿病。口服葡萄糖耐量试验(OGTT)可提高对糖耐量受损(IGT)和糖尿病患者的检测率。
评估在血管外科手术患者中,OGTT相对于空腹血糖水平在预测长期心血管结局方面的附加价值。
前瞻性纳入404例无IGT(血糖7.8 - 11.1 mmol/L)或DM(血糖≥11.1 mmol/L)体征或病史的患者,并进行OGTT。记录心脏危险因素。主要结局是晚期心血管事件的发生(心血管死亡、心绞痛、心肌梗死、经皮冠状动脉介入治疗/冠状动脉搭桥术,或脑血管意外/短暂性脑缺血发作的复合事件),次要结局包括血管外科手术幸存者的全因死亡率和心血管死亡率。中位随访时间为3.0(四分位间距2.4 - 3.8)年。
通过空腹血糖水平分别在26例(25%)和12例(28%)患者中检测到糖耐量受损(n = 104)和糖尿病(n = 43),而通过OGTT分别在78例(75%)和31例(72%)患者中检测到。在随访期间,131例患者发生了心血管事件。多变量分析显示,IGT患者发生心血管事件的风险显著增加(风险比2.77,95%可信区间1.83 - 4.20),死亡风险也显著增加(风险比2.06,95%可信区间1.03 - 4.12)。糖尿病患者发生心血管事件的风险增加但无统计学意义。
术前OGTT检测出的IGT或DM血管外科手术患者在长期随访期间发生心血管事件和死亡的风险增加。建议对非糖尿病血管外科手术患者在术前进行血糖调节障碍检测。